Moreover, in colon cancer, miR-34a has been shown to inhibit the expression of numerous ATP-binding cassette (ABC) transporters such as MRP2, P-gp and BCRP, as well as antiapoptotic genes like Bcl-2, all of which contribute to chemoresistance. This evidence concerns the gene BCL2 and colonic neoplasm.